Financials
- Market Capitalization 1.09 B
- Employee 121
- Founded 2013
- CEO N/A
- Website www.solidbio.com
- Headquarter Delaware, United States
- FIGI BBG00JN4FXG8
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-2.83
Rapporto prezzo/fatturato
530.1
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2377 | JANX Janux Therapeutics, Inc. - Common Stock | 18.78 USD | -0.58% | +7.93% | +25.87% | -18.70% | 1.15 B USD | ||
| 2388 | SVRA Savara, Inc. - Common Stock | 5.49 USD | -2.14% | -0.90% | +4.17% | +67.89% | 1.13 B USD | ||
| 2421 | AVTX Avalo Therapeutics, Inc. - Common Stock | 20.05 USD | -2.43% | +0.15% | +1.88% | +112.85% | 1.08 B USD | ||
| 2428 | CADL Candel Therapeutics, Inc. - Common Stock | 13.75 USD | +3.54% | +8.70% | +40.16% | +135.04% | 1.05 B USD |